![]() ![]() ![]() Otherwise I really can't recommend this show. If you've been a follower of the manga, sure, just watch it, Story-wise, the first two episodes was according to manga, but later drifted away. This anime is somewhat a shame that compared to the manga. The anime ended in an incomplete way, the relationship was really rushed and forced. However, the real problem is that the show was only 6 episodes long, each being less than 15 mins long. The anime did a proper job displaying the character's personalities too. Nothing wrong with Chinese or Japanese audio either. To eliminate the scum of the vanguards, a battle between two vanguards begins.įor the anime, the initial episodes (1 and 2) were actually rather great, loved the animation and such. As a vanguard, Liuli feels deep contempt against Zhou. The former vanguard Zhongrong Zhou cries and asks the government to hand over the son of Eden. However, Liuli obediently decides to accept the mission in the end.ĭuring the mission, Liuli surprisingly finds that the man who holds the hostage was once a vanguard. It is without doubt a difficult mission for a vanguard like Liuli, who only knows how to kill and battle. With only 380 days left in her life, Liuli receives a new mission, to rescue a hostage being held in a civilian facility. The heroine Liuli has also consumed too much of her lifespan after executing missions for a long time. Usually, most vanguards will retire from the army after a number of years in service. Although vanguards are exceptionally combat-effective, their life expectancy is shortened by the nanomachines they use. Vanguards, as the most significant achievement of the modern bioengineering and the most advanced weapon, are widely utilized in the race. However, all the new technologies are put into military use, beginning a new round of arms race. In 2017, a group of genius scientists achieve a remarkable breakthrough in bioengineering. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |